Reduced-Intensity Conditioning (RIC) in Children with Nonmalignant Disorders (NMD) Undergoing Unrelated Donor Umbilical Cord Blood Transplantation (UCBT)

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 1 SUPPL., 2012, Pages

  Parikh, Suhag ^a   Szabolcs, Paul ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; THIOTEPA;

ARTICLE; BLOOD DONOR; CHILDHOOD DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; FOLLOW UP; GENETIC DISORDER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMOGLOBINOPATHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MORBIDITY; MORTALITY; NONMALIGNANT DISORDER; NONMYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL; RADIATION DOSE; REDUCED INTENSITY CONDITIONING; SICKLE CELL ANEMIA;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEMOGLOBINOPATHIES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; LIVER; MALE; TRANSPLANTATION CONDITIONING;

EID: 84855376277     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.10.013     Document Type: Article

References (27)

1. Walters M.C., Patience M., Leisenring W., et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996, 335:369-376.
2. Gluckman E., Auerbach A.D., Horowitz M.M., et al. Bone marrow transplantation for Fanconi anemia. Blood 1995, 86:2856-2862.
3. Boelens J.J., Prasad V.K., Tolar J., Wynn R.F., Peters C. Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin North Am 2010, 57:123-145.
4. Szabolcs P., Cavazzana-Calvo M., Fischer A., Veys P. Bone marrow transplantation for primary immunodeficiency diseases. Pediatr Clin North Am 2010, 57:207-237.
5. Fratantoni J., Hall C., Neufeld E.F. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 1968, 162:570-572.
6. Kurtzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996, 335:157-166.
7. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997, 337:373-381.
8. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339:1565-1577.
9. Kurtzberg J., Prasad V.K., Carter S.L., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008, 112:4318-4327.
10. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100:1611-1618.
11. Martin P.L., Carter S.L., Kernan N.A., et al. Results of the Cord Blood Transplantation Study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006, 12:184.
12. Arcese W., Rocha V., Labopin M., et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006, 91:223-230.
13. Sanders J.E. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 2007, 41:223-227.
14. Satwani P., Cooper N., Rao K., Veys P., Amrolia P. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 2008, 41:173-182.
15. Andreani M., Nesci S., Lucarelli G., et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant 2000, 25:401-404.
16. Walters M.C., Patience M., Leisenring W., et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001, 7:665-673.
17. Iannone R., Casella J.F., Fuchs E.J., et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003, 9:519-528.
18. Hsieh M.M., Kang E.M., Fitzhugh C.D., et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009, 361:2309-2317.
19. Resnick I.B., Aker M., Tsirigotis P., et al. Allogeneic stem cell transplantation from matched related and unrelated donors inthalassemia major patients using a reduced toxicity fludarabine-based regimen. Bone Marrow Transplant 2007, 40:957-964.
20. Jacobsohn D.A., Duerst R., Tse W., Kletzel M. Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 2004, 364:156-162.
21. Krishnamurti L., Kharbanda S., Biernacki M.A., et al. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 2008, 14:1270-1278.
22. Rao K., Amrolia P.J., Jones A., et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005, 105:879-885.
23. Shenoy S., Grossman W.J., DiPersio J., et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2004, 35:345-352.
24. Marsh R.A., Vaughn G., Kim M.-O., et al. Reduced-intensity conditioning significantly improves survival of patients withhemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 2010, 116:5824-5831.
25. Veys P. Reduced intensity transplantation for primary immunodeficiency disorders. Immunol Allergy Clin North Am 2010, 30:103-124.
26. Satwani P., Jin Z., Duffy D., et al. Reduced toxicity conditioning (RTC) and allogeneic stem cell transplantation (alloSCT) in 100 consecutive pediatric recipients: very low incidence of day 100 transplant related mortality (TRM). Biol Blood Marrow Transplant 2011, 17:S265.
27. Parikh S.H., Martin P.L., Driscoll T.A., et al. A prospective study of reduced intensity conditioning (RIC) in children undergoing unrelated umbilical cord blood transplantation (UCBT) for non-malignant diseases: preliminary results demonstrate a high rate of engraftment and low incidence of GVHD. Biol Blood Marrow Transplant 2011, 17:S265-S266.